Cannabidiol as an Adjunctive Treatment for Bipolar Depression (CBDBD)
A Double-blind, Randomized, Placebo-controlled Clinical Trial of Adjunctive Cannabidiol for Bipolar Depression
Sponsor: Federal University of Rio Grande do Sul
Terminated
It was interrupted due to the coronavirus pandemic outbreak.
Other terminated trials from Federal University of Rio Grande do Sul
- Intensive Care Unit Acquired Weakness · Phase NA · Jun 2024
- Actinic Cheilitis · Phase PHASE1 · Aug 2021
- Hypertension · Phase NA · Dec 2016
See all terminations from Federal University of Rio Grande do Sul
This PHASE2/PHASE3 trial investigates Bipolar Affective Disorder and Bipolar Depression and is currently terminated or withdrawn. Federal University of Rio Grande do Sul leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
Status: Recruiting → Terminated
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 6 earlier versions
-
Sep 2019 — Apr 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2019 — Sep 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2018 — Jan 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE2_PHASE3
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — May 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Federal University of Rio Grande do Sul
- Hospital de Clinicas de Porto Alegre
- University of Sao Paulo
For direct contact, visit the study record on ClinicalTrials.gov .